DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Whooping cough/Pertussis - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Whooping cough/Pertussis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the diseas...
January 2022
60 pages
Wilms Tumor - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Wilms Tumor - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical...
January 2022
60 pages
Wiskott-Aldrich Syndrome - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Wiskott-Aldrich Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the diseas...
January 2022
60 pages
Yellow Fever - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Yellow Fever - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historica...
January 2022
60 pages
Zollinger Ellison Syndrome - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Zollinger Ellison Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the dise...
January 2022
60 pages
Basal cell carcinoma - Pipeline Insight, 2021
US$ 2,000.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Basal Cell Carcinoma (Basal Cell Epithelioma) The report also ...
October 2021
70 pages
Chondrosarcoma - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Chondrosarcoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Chondrosarcoma development. The report provides detailed ...
October 2021
60 pages
Binge-eating disorder - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Binge Disorders - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Binge Disorders development. The report provides ...
October 2021
60 pages
Herpes labialis - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Herpes Labialis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Herpes Labialis development. The report provides ...
October 2021
60 pages
Hypertriglyceridemia - Pipeline Insight, 2021
US$ 2,000.00
... clients within 48 Hours 'Hypertriglyceridemia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hypertriglyceridemia development. The report provides detailed ...
October 2021
60 pages
Liposarcoma - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Liposarcoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Liposarcoma development. The report provides detailed ...
October 2021
60 pages
Medulloblastoma - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Medulloblastoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Medulloblastoma development. The report provides detailed ...
October 2021
60 pages
Myelofibrosis - Pipeline Insight, 2021
US$ 2,000.00
... clients within 48 Hours 'Myelofibrosis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Myelofibrosis development. The report provides detailed ...
October 2021
80 pages
Peptic Ulcer - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Peptic Ulcers - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Peptic Ulcers development. The report provides ...
October 2021
60 pages
Pulmonary Embolism - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Pulmonary Embolism - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Pulmonary Embolism development. The report provides ...
October 2021
60 pages
Rosacea - Pipeline Insight, 2021
US$ 2,000.00
... clients within 48 Hours 'Rosacea - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Rosacea development. The report provides detailed ...
October 2021
60 pages
Narcolepsy - Pipeline Insight, 2021
US$ 1,500.00
... Narcolepsy - Pipeline Insight, 2018' report by DelveInsight outlays comprehensive Insight of present scenario and growth prospects across Narcolepsy. A detailed picture of the pipeline ... and Discontinued) Overview of pipeline development activities for Narcolepsy Pipeline analysis of therapeutic drugs include ...
October 2021
60 pages
Ataxia-telangiectasia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “Ataxia-telangiectasia - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipelin...
October 2021
60 pages
Beta-thalassaemia - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 3-4 Business Days DelveInsight’s, “Beta-thalassaemia - Pipeline Insight, 2021,” report provides comprehensive insights about 22+ companies and 22+...
October 2021
60 pages
Bullous pemphigoid - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 3-4 Business Days DelveInsight’s, “Bullous pemphigoid - Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ p...
October 2021
60 pages
Carcinoid Syndrome - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “Carcinoid Syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline d...
October 2021
60 pages
Gaucher’s Disease - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Gaucher’s Disease - Pipeline Insight, 2021,” report provides comprehensive insights about 14+ companies and 16+ pipeline...
October 2021
60 pages
Lyme Disease - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 72 hours DelveInsight’s, “Lyme Disease - Pipeline Insight, 2021,” report provides comprehensive insights about 7+ companies and 7+ pipeline drugs i...
October 2021
60 pages
Muscle Spasticity - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Muscle Spasticity – Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ pipeline dr...
October 2021
60 pages
Neurofibromatosis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Neurofibromatosis - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline...
October 2021
60 pages
Presbyopia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Presbyopia - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs i...
October 2021
60 pages
Primary Ciliary Dyskinesia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “Primary Ciliary Dyskinesia – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pi...
October 2021
60 pages
Chronic Rhinosinusitis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Chronic Rhinosinusitis - Pipeline Insight, 2021,” report provides comprehensive insights about 6+ companies and 6+ pipeli...
October 2021
60 pages